MOHAMMADREZA AZADFARD: Open Payments
NPI 1689841488 · BATAVIA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 27 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $211 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $146 |
| Exact Sciences Corporation | 4 | $72 |
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
| Cumberland Pharmaceuticals, Inc. | 3 | $48 |
| Indivior Inc. | 2 | $41 |
| Lilly USA, LLC | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Cranial Technologies, Inc | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Ozempic, Cologuard Collection Kit, Qelbree, KRISTALOSE, SUBLOCADE, MOUNJARO, Wegovy, Kerendia.
Industry payments across NY — which companies pay providers there.
